Publications:

Longitudinal analysis of treatment-induced genomic alterations in gliomas.

Genome Medicine

Erson-Omay, E Zeynep EZ; Henegariu, Octavian O; Omay, S Bülent SB; Harmancı, Akdes Serin AS; Youngblood, Mark W MW; Mishra-Gorur, Ketu K; Li, Jie J; Özduman, Koray K; Carrión-Grant, Geneive G; Clark, Victoria E VE; Çağlar, Caner C; Bakırcıoğlu, Mehmet M; Pamir, M Necmettin MN; Tabar, Viviane V; Vortmeyer, Alexander O AO; Bilguvar, Kaya K; Yasuno, Katsuhito K; DeAngelis, Lisa M LM; Baehring, Joachim M JM; Moliterno, Jennifer J; Günel, Murat M

Publication Date: 2017-02-02

Variant appearance in text: MSH6: F265C

PubMed Link: 28153049

Variant Present in the following documents:

• 13073_2017_401_MOESM3_ESM.xlsx, sheet 2

View BVdb publication page

Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research

Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C

Publication Date: 2011-09-01

Variant appearance in text: MSH6: F265C

PubMed Link: 21727090

Variant Present in the following documents:

• supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1

View BVdb publication page

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Cahill, Daniel P DP; Levine, Kymberly K KK; Betensky, Rebecca A RA; Codd, Patrick J PJ; Romany, Candice A CA; Reavie, Linsey B LB; Batchelor, Tracy T TT; Futreal, P Andrew PA; Stratton, Michael R MR; Curry, William T WT; Iafrate, A John AJ; Louis, David N DN

Publication Date: 2007-04-01

Variant appearance in text: MSH6: F265C

PubMed Link: 17404084

Variant Present in the following documents:

• Main text

View BVdb publication page